A detailed history of Nicholas Investment Partners, LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 5,636 shares of VRTX stock, worth $2.91 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
5,636
Previous 4,343 29.77%
Holding current value
$2.91 Million
Previous $1.82 Million 45.51%
% of portfolio
0.31%
Previous 0.21%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$392.81 - $485.53 $507,903 - $627,790
1,293 Added 29.77%
5,636 $2.64 Million
Q1 2024

May 13, 2024

SELL
$407.69 - $446.08 $1.42 Million - $1.55 Million
-3,479 Reduced 44.48%
4,343 $1.82 Million
Q4 2023

Feb 07, 2024

SELL
$343.0 - $410.68 $29.8 Million - $35.7 Million
-86,936 Reduced 91.75%
7,822 $3.18 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $4.95 Million - $5.31 Million
14,642 Added 18.28%
94,758 $33 Million
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $3.2 Million - $3.58 Million
-10,175 Reduced 11.27%
80,116 $28.2 Million
Q1 2023

May 11, 2023

BUY
$283.23 - $323.1 $11.9 Million - $13.6 Million
42,050 Added 87.17%
90,291 $28.4 Million
Q4 2022

Feb 10, 2023

SELL
$285.76 - $321.48 $4.15 Million - $4.67 Million
-14,538 Reduced 23.16%
48,241 $13.9 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $194,419 - $216,926
710 Added 1.14%
62,779 $18.2 Million
Q1 2022

May 10, 2022

BUY
$221.42 - $260.97 $5.27 Million - $6.21 Million
23,782 Added 62.12%
62,069 $16.2 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $6.78 Million - $8.56 Million
38,287 New
38,287 $8.41 Million
Q2 2019

Aug 09, 2019

SELL
$164.61 - $190.37 $2.34 Million - $2.71 Million
-14,214 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $1.88 Million - $2.24 Million
11,489 Added 421.61%
14,214 $2.62 Million
Q4 2018

Feb 14, 2019

BUY
$151.91 - $192.21 $22,634 - $28,639
149 Added 5.78%
2,725 $452,000
Q3 2018

Nov 14, 2018

BUY
$167.73 - $192.74 $432,072 - $496,498
2,576 New
2,576 $496,000
Q2 2018

Aug 14, 2018

SELL
$145.72 - $169.96 $4.77 Million - $5.56 Million
-32,709 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$151.6 - $177.13 $958,870 - $1.12 Million
6,325 Added 23.97%
32,709 $5.33 Million
Q4 2017

Feb 14, 2018

SELL
$137.28 - $155.55 $1.88 Million - $2.13 Million
-13,667 Reduced 34.12%
26,384 $3.95 Million
Q3 2017

Nov 13, 2017

BUY
$148.13 - $162.24 $5.93 Million - $6.5 Million
40,051
40,051 $6.09 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.